ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625516; 2) Community: the network communities that were significantly associated with the response to NSC 625516; 3) Molecule: the relationships between components within communities and NSC 625516; 4) MDR: the compounds that were significantly associated with the NSC 625516.

NSC Compound Enrichment Correlation
NSC 650792 1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- 0.0102077332082017 -0.26503206
NSC 681645 Camptothecin Derivative 0.0102077332082017 0.10480281
NSC 700893 5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) 0.0102077332082017 -0.29629497
NSC 142475 Null 0.0102962192514438 0.32590713
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0102962192514438 0.4185578
NSC 180973 Tamoxifen citrate 0.0102962192514438 0.49653591
NSC 32924 Null 0.0102962192514438 0.20708955
NSC 382046 Null 0.0102962192514438 0.38087353
NSC 617989 3-Deazaneplanocin, hydrochloride 0.0102962192514438 0.44609606
NSC 626541 Null 0.0102962192514439 0.55135113
Total:147  Current:55    [First] [Prev] [Next] [Last]